D.A. Davidson & Co’s Niagen Bioscience NAGE Stock Holding History

D.A. Davidson & Co’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-26,942	Closed	-$251K	–	1615
2025 Q3	$251K	Sell	26,942 -10,032	-27%	-$101K	﹤0.01%	1361
2025 Q2	$533K	Buy	36,974 +25,224	+215%	+$249K	﹤0.01%	1027
2025 Q1	$81.1K	Buy	+11,750	New	+$73.8K	﹤0.01%	1372
2022 Q1	–	Sell	-21,000	Closed	-$79K	–	1350
2021 Q4	$79K	Sell	21,000 -2,000	-9%	-$10.8K	﹤0.01%	1244
2021 Q3	$144K	Sell	23,000 -1,000	-4%	-$8.24K	﹤0.01%	1171
2021 Q2	$237K	Hold	24,000	–	–	﹤0.01%	1077
2021 Q1	$224K	Sell	24,000 -14,500	-38%	-$115K	﹤0.01%	1056
2020 Q4	$185K	Hold	38,500	–	–	﹤0.01%	970
2020 Q3	$154K	Buy	38,500 +1,500	+4%	+$7.24K	﹤0.01%	903
2020 Q2	$170K	Buy	37,000 +2,000	+6%	+$8.95K	﹤0.01%	879
2020 Q1	$114K	Hold	35,000	–	–	﹤0.01%	925
2019 Q4	$151K	Hold	35,000	–	–	﹤0.01%	972
2019 Q3	$138K	Hold	35,000	–	–	﹤0.01%	940
2019 Q2	$163K	Sell	35,000 -10,000	-22%	-$42.7K	﹤0.01%	921
2019 Q1	$189K	Hold	45,000	–	–	﹤0.01%	1050
2018 Q4	$154K	Hold	45,000	–	–	﹤0.01%	1013
2018 Q3	$193K	Hold	45,000	–	–	﹤0.01%	1083
2018 Q2	$167K	Buy	45,000 +1,000	+2%	+$3.8K	﹤0.01%	1044
2018 Q1	$185K	Hold	44,000	–	–	﹤0.01%	1017
2017 Q4	$259K	Buy	44,000 +1,000	+2%	+$5.4K	0.01%	905
2017 Q3	$184K	Buy	43,000 +5,000	+13%	+$18.3K	﹤0.01%	1025
2017 Q2	$145K	Hold	38,000	–	–	﹤0.01%	1099
2017 Q1	$102K	Buy	38,000 +6,000	+19%	+$17K	﹤0.01%	1243
2016 Q4	$105K	Sell	32,000 -10,000	-24%	-$27.2K	﹤0.01%	1284
2016 Q3	$125K	Hold	42,000	–	–	﹤0.01%	1149
2016 Q2	$173K	Buy	+42,000	New	+$199K	0.01%	893

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.A. Davidson & Co's NAGE Position: Q4 2025 in Review

D.A. Davidson & Co sold out of Niagen Bioscience (NAGE) in Q4 2025, closing a stake of 26,942 shares — an estimated $251K sold.

D.A. Davidson & Co first reported a position in NAGE in Q2 2016 and held it in 26 quarters. The position peaked at $533K in Q2 2025. 169 funds tracked by Wall St. Rank hold NAGE as of Q4 2025.

D.A. Davidson & Co reported no remaining Niagen Bioscience position as of Q4 2025 after selling out during the quarter.
D.A. Davidson & Co sold 26,942 Niagen Bioscience shares in Q4 2025, an estimated $251K.
D.A. Davidson & Co first reported a position in Niagen Bioscience in Q2 2016 and held it in 26 quarters.
D.A. Davidson & Co's Niagen Bioscience position peaked at $533K in Q2 2025.
169 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2025.

Based on D.A. Davidson & Co's 13F filing for Q4 2025, filed 29 Jan 2026.